224 related articles for article (PubMed ID: 9672342)
1. Prevalence and significance of steatorrhea in patients with active Graves' disease.
Goswami R; Tandon RK; Dudha A; Kochupillai N
Am J Gastroenterol; 1998 Jul; 93(7):1122-5. PubMed ID: 9672342
[TBL] [Abstract][Full Text] [Related]
2. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokines levels in Graves' disease.
Al-Humaidi MA
Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
6. [Fecal chymotrypsin and steatorrhea in chronic pancreatitis].
Montalto G; Carroccio A; Soresi M; Di Martino D; Ippolito S; La Rocca G; Notarbartolo A
Minerva Gastroenterol Dietol; 1992; 38(1):15-9. PubMed ID: 1520749
[TBL] [Abstract][Full Text] [Related]
7. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
8. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
9. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.
Chu CH; Lee JK; Keng HM; Chuang MJ; Lu CC; Wang MC; Sun CC; Wei MC; Lam HC
Exp Biol Med (Maywood); 2006 Jun; 231(6):1040-3. PubMed ID: 16741045
[TBL] [Abstract][Full Text] [Related]
10. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment.
Zimmermann-Belsing T; Juul A; Juul Holst J; Feldt-Rasmussen U
Growth Horm IGF Res; 2004 Jun; 14(3):235-44. PubMed ID: 15125885
[TBL] [Abstract][Full Text] [Related]
11. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea.
Lembcke B; Grimm K; Lankisch PG
Am J Gastroenterol; 1987 Jun; 82(6):526-31. PubMed ID: 3646827
[TBL] [Abstract][Full Text] [Related]
12. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
El Refaei SM; Shawkat W
Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
[TBL] [Abstract][Full Text] [Related]
13. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
[TBL] [Abstract][Full Text] [Related]
14. High iodine (substrate) turnover Graves' disease: the intriguing 'rapid responder' variant of thyrotoxicosis.
Dalan R; Leow MK; Ng DC
Ann Clin Biochem; 2008 Nov; 45(Pt 6):612-5. PubMed ID: 18941129
[TBL] [Abstract][Full Text] [Related]
15. [Stimulation of endogenous TSH secretion and endocrine orbitopathy].
Wuttke H; Schlieter D
Med Klin; 1980 Aug; 75(18):658-62. PubMed ID: 6158667
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
17. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis.
Safdi M; Bekal PK; Martin S; Saeed ZA; Burton F; Toskes PP
Pancreas; 2006 Aug; 33(2):156-62. PubMed ID: 16868481
[TBL] [Abstract][Full Text] [Related]
18. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
19. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
20. T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.
Mastorakos G; Doufas AG; Mantzos E; Mantzos J; Koutras DA
J Endocrinol Invest; 2003 Oct; 26(10):979-84. PubMed ID: 14759070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]